Trials / Completed
CompletedNCT03457792
A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis
Abatacept in Early-Stage Rheumatoid Arthritis Patients: Longterm Experience and Efficacy in Routine Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 158 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a long-term study of Abatacept in participants that only recently started to develop Rheumatoid Arthritis, a chronic inflammatory disorder affecting mainly joints.
Conditions
Timeline
- Start date
- 2018-04-17
- Primary completion
- 2022-03-30
- Completion
- 2022-03-30
- First posted
- 2018-03-08
- Last updated
- 2022-06-14
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03457792. Inclusion in this directory is not an endorsement.